Saturday, August 26,2017 Survivorship (Julie Spears APRN-CNS, MS) Bone Marrow Transplant Update (Joe Lynch MD) Genetic Counseling Myths and Misconceptions – What You Need to Know (Lori A Carpenter MS, CGC, LGC) Overview of Immunotherapy (Emily Borders PharmD BCOP) Update … Continued
Saturday, August 19, 2017 Advances in Breast Cancer Treatment: Anti-HER2 Therapy, PARP Inhibition, and Immunotherapy.(Sarah Moughalian MD) The Pain of Pleasure: Heroin and Other Opiods The Implications for Oncology Practice: A Clinical Dilemma (Merrill Norton PharmD) GI Update (Richard Goldberg … Continued
U.S. Food and Drug Administration today approved Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds … Continued
On September 22, 2017, the Food and Drug Administration granted accelerated approval to nivolumab (OPDIVO, Bristol-Myers Squibb Co.) for the treatment of hepatocellular carcinoma (HCC) in patients who have been previously treated with sorafenib.